Erbitux Trial Awaits Judge's Decision
After hearing closing arguments on Wednesday, a Manhattan district court judge must now decide whether three Israeli scientists should be named co-inventors of the blockbuster cancer drug Erbitux....To view the full article, register now.
Already a subscriber? Click here to view full article